New FDA Rule Broadens Scope Of Clinical Investigator Bans

Law360, New York (April 27, 2012, 3:57 PM EDT) -- A U.S. Food and Drug Administration rule released Friday would disqualify clinical investigators who are ineligible to conduct preapproval studies of one type of FDA-regulated product — like drugs or medical devices — from conducting studies for other types, too.

The FDA said the rule comes in response to a September 2009 report from the Government Accountability Office, which pointed out that an investigator who is disqualified from conducting clinical studies in support of FDA approval for one category of products, like drugs, would still be...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.